Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Leukemia

Free Subscription 14.09.2026 2 Acta Haematol 1 Am J Hematol 1 Ann Hematol 1 Biochem Biophys Res Commun 2 Biochem Pharmacol 1 Blood 3 Bone Marrow Transplant 10 Br J Haematol 2 Eur J Haematol 1 Genes Chromosomes Cancer 1 Int J Hematol 1 J Biol Chem 1 J Pediatr Hematol Oncol 3 Leuk Lymphoma 4 Leuk Res 1 Leukemia 1 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. KOBAYASHI T, Matsushima S, Ohnishi H
   T-Cell Leukemia Cell Line Harboring Previously Undescribed CBFB::MYL11 Fusion Exhibits a Genome Profile Implicating Cytoskeletal Abnormality.
   Acta Haematol. 2026 Sep 11:1. doi: 10.1159.
   PubMed         Abstract available
   
   
2. SYAL A, Tremblay D
   Inferior Survival in Therapy-Related Chronic Myelomonocytic Leukemia: A Population-Based Analysis.
   Acta Haematol. 2026 Sep 9:1. doi: 10.1159.
   PubMed         Abstract available
   
   

   
   Am J Hematol

3. KWON AJ, Hill LK, Tachibana R, Oertling E, et al
   Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.
   Am J Hematol. 2026 Sep 5. doi: 10.1002/ajh.70494.
   PubMed        
   
   

   
   Ann Hematol

4. DU Y, Zhang J, Jin S
   A case report of CD4(-) CD8(+) CD56(-) TCRgammadelta(+) T-large granular lymphocytic leukaemia with severe aplastic anemia and a PNH clone.
   Ann Hematol. 2026 Jun 29. doi: 10.1007/s00277-026-07141.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. SUZUKI R, Ogawa R, Furuno T
   Monomeric hapten dissociates FcepsilonRI-evoked STIM1-Orai1 interaction and immediately terminates Ca(2+) influx in rat basophilic leukemia cells.
   Biochem Biophys Res Commun. 2026;835:154539.
   PubMed         Abstract available
   
   

   
   Biochem Pharmacol

6. LI S, Yang Y, Liu D, Huang M, et al
   BMAL1 mediates venetoclax resistance in acute myeloid leukemia by interacting with TPD52.
   Biochem Pharmacol. 2026 Sep 11:118472. doi: 10.1016/j.bcp.2026.118472.
   PubMed         Abstract available
   
   
7. HOSONO N, Ida N, Yamauchi T
   Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.
   Biochem Pharmacol. 2026 Sep 6:118440. doi: 10.1016/j.bcp.2026.118440.
   PubMed         Abstract available
   
   

   
   Blood

8. XU Z, Roland K
   Cuplike nuclei and bimodal CD34 expression in adult KMT2A-rearranged pro-B acute lymphoblastic leukemia.
   Blood. 2026;148:1515.
   PubMed        
   
   

   
   Bone Marrow Transplant

9. DUQUE-AFONSO J, Finke J, Ferhat-Berland T, Galimard JE, et al
   Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of
   Bone Marrow Transplant. 2026 Sep 10. doi: 10.1038/s41409-026-03016.
   PubMed         Abstract available
   
   
10. BERTON G, Furst S, Bouchacourt B, Harbi S, et al
    Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patients.
    Bone Marrow Transplant. 2026;61:1188-1195.
    PubMed         Abstract available
    
    
11. AVENOSO D, Radici V, Leoni A, Skert C, et al
    A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first compl
    Bone Marrow Transplant. 2026 Jun 24. doi: 10.1038/s41409-026-02937.
    PubMed         Abstract available
    
    

    
    Br J Haematol

12. RUI M, Cheung YT, Zhang H, Wei Q, et al
    Blinatumomab for treatment of children with acute lymphoblastic leukaemia in Hong Kong: A cost-effectiveness analysis.
    Br J Haematol. 2026;209:1146-1157.
    PubMed         Abstract available
    
    
13. PLAYA-ALBINYANA H, Giro A, Pineyroa JA, Araujo-Ayala F, et al
    Scaffold-free three-dimensional culture of chronic lymphocytic leukaemia preserves B-T-cell cross-talk and enables drug response profiling.
    Br J Haematol. 2026;209:953-963.
    PubMed         Abstract available
    
    
14. KATSIMIGAS A, Werling M, Frederiksen CM, Vainer N, et al
    Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in a nationwide cohort.
    Br J Haematol. 2026 Jul 1. doi: 10.1111/bjh.70651.
    PubMed         Abstract available
    
    
15. DUMINUCO A, Leotta D, Allegra A, Caracciolo D, et al
    Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.
    Br J Haematol. 2026;209:1010-1019.
    PubMed         Abstract available
    
    
16. KHAN A, Gajendra S, Rai S, Thakral D, et al
    Leukaemic stem cell burden enhances prognostic precision in the non-adverse European LeukemiaNet risk group of acute myeloid leukaemia.
    Br J Haematol. 2026;209:1119-1127.
    PubMed         Abstract available
    
    
17. LIU Q, Wang X, Fan J, Zheng Y, et al
    DHX15 affects AML1-ETO9a splicing together with HNRNPL, RBM33 in AML1-ETO-positive acute myeloid leukaemia.
    Br J Haematol. 2026;209:964-977.
    PubMed         Abstract available
    
    
18. SHIMIZU K, Saito MK, Maringe C, Miyazaki Y, et al
    Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.
    Br J Haematol. 2026;209:1128-1135.
    PubMed         Abstract available
    
    
19. CHAN WY, Al-Yousuf H, Lam HPJ, Leong S, et al
    Real-world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS-like tyrosine kinase 3 (FLT3)-mutated relapsed/refractory acute myeloid leukaemia: A UK single-centre experience.
    Br J Haematol. 2026;209:1386-1390.
    PubMed         Abstract available
    
    
20. YANG Y, Tang Y, Yang K, Zhang Y, et al
    CCAAT/enhancer-binding protein alpha basic leucine zipper in-frame insertion/deletion (CEBPA bZIP-InDel-inf) defines a favourable-prognosis subgroup in CEBPA-mutated acute myeloid leukaemia.
    Br J Haematol. 2026;209:1136-1145.
    PubMed         Abstract available
    
    
21. ROSEN N, Rodriguez-Real G, Vom Stein AF, Schreurs LD, et al
    Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression.
    Br J Haematol. 2026;209:939-952.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

22. DAMPMANN M, Flossdorf S, Keyl J, Leitner T, et al
    Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.
    Eur J Haematol. 2026 Sep 11. doi: 10.1111/ejh.70319.
    PubMed         Abstract available
    
    
23. FORGHIERI F, Cordella S, Lazzarotto D, Annunziata M, et al
    Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric-Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study.
    Eur J Haematol. 2026 Sep 8. doi: 10.1111/ejh.70317.
    PubMed         Abstract available
    
    

    
    Genes Chromosomes Cancer

24. NAGAI J, Yoshida S, Teshima T, Onozawa M, et al
    Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia.
    Genes Chromosomes Cancer. 2026;65:e70171.
    PubMed         Abstract available
    
    

    
    Int J Hematol

25. URESHINO H
    Road to treatment-free remission in chronic myeloid leukemia.
    Int J Hematol. 2026 Sep 11. doi: 10.1007/s12185-026-04278.
    PubMed         Abstract available
    
    

    
    J Biol Chem

26. STEWART E, Collins A, Kovacic B, Knupke M, et al
    Pathway incompatibility between NF-kappaB and RAS signaling constrains oncogenicity in B-cell leukemia.
    J Biol Chem. 2026 Sep 8:113537. doi: 10.1016/j.jbc.2026.113537.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

27. KHAN M, Saeed W
    Comments on "Initial Cerebrospinal Fluid Blast Clearance Rate in Pediatric B-Lymphoblastic Leukemia Is Associated With Overall Survival".
    J Pediatr Hematol Oncol. 2026 Sep 9. doi: 10.1097/MPH.0000000000003269.
    PubMed        
    
    

    
    Leuk Lymphoma

28. PAPADAKI A, Baker R, Nacheva E, O'Nions J, et al
    Targeted RNA sequencing supports risk stratification and treatment decision-making in adolescents and young adult and adult patients with acute lymphoblastic leukemia: a UK single-center experience.
    Leuk Lymphoma. 2026 Sep 6:1-4. doi: 10.1080/10428194.2026.2726608.
    PubMed        
    
    
29. GOSHIMA Y, Saika T, Kado Y, Yamazaki M, et al
    Response to Borras-Blasco et al. regarding "Real-world venetoclax dosing patterns and treatment persistence in patients with acute myeloid leukemia: a community pharmacy database study in Japan".
    Leuk Lymphoma. 2026 Sep 6:1-2. doi: 10.1080/10428194.2026.2724604.
    PubMed        
    
    
30. FARAG CM, Mercurio A, Rouf R, Fried H, et al
    Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.
    Leuk Lymphoma. 2026 Sep 6:1-12. doi: 10.1080/10428194.2026.2724605.
    PubMed         Abstract available
    
    

    
    Leuk Res

31. KOBAYASHI T, Matsushima S, Ohnishi H
    Identification and characterization of ectopic chromosomal amplifications in acute myeloid leukemia cell limes using high-throughput chromosome conformation capture screening.
    Leuk Res. 2026;170:108304.
    PubMed         Abstract available
    
    
32. ZHUANG W, Huang C, Ma X, Huang Y, et al
    Construction and evaluation of a machine-learning-based prediction model for pneumonia in patients with acute leukemia.
    Leuk Res. 2026;170:108302.
    PubMed         Abstract available
    
    
33. AMITAI I, Zlotnik M, Ram R, Amit O, et al
    Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.
    Leuk Res. 2026;169:108299.
    PubMed         Abstract available
    
    
34. DA SILVA AMM, Silva VR, Chung-Filho AA, Sampaio GP, et al
    Treatment outcome in pediatric patients with T-ALL in Brazil.
    Leuk Res. 2026;169:108287.
    PubMed         Abstract available
    
    

    
    Leukemia

35. ZINZ R, Rohde C, Pauli C, Zhou F, et al
    Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.
    Leukemia. 2026 Sep 4. doi: 10.1038/s41375-026-03120.
    PubMed         Abstract available
    
    

    
    Oncogene

36. MAHARJAN CK, Liu Y, Xiao Y, Podder BR, et al
    PROTAC-mediated targeting of IKKbeta and NR4A1 for AML therapy.
    Oncogene. 2026;45:3921-3934.
    PubMed         Abstract available
    
    

    
    PLoS One

37. KIM SH
    Stage-specific evolutionary dynamics in pediatric leukemia inferred using Bayesian stochastic modeling.
    PLoS One. 2026;21:e0357755.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum